Pfizer RSV vaccine wins recommendation for seasonal use only; exclusive: Markey and Manchin urge FDA to stop opioid study

Taking stock of the drug industry, from the lab to the medicine chest

September 22, 2023 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Courtesy Pfizer Pfizer RSV vaccine wins recommendation for seasonal use only The recommendation must be accepted by CDC Director Mandy Cohen before the Pfizer vaccine can begin to be used. By Helen Branswell Markey and Manchin urge FDA to stop its study of opioids for chronic pain Ed Markey and Joe Manchin object to the design of a trial meant to reassess opioids' effectiveness for chronic pain. By Lev Facher STAT+ | Breast cancer drug from AstraZeneca, Daiichi hits goal in late-stage trial A drug from AstraZeneca tamped down the progression of breast cancer, after the same drug produced underwhelming results in lung cancer. By Andrew Joseph Alex Hogan/STAT STAT+ | Up and down the ladder: The latest comings and goings From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry. By Ed Silverman

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser